Shopping Cart
- Remove All
Your shopping cart is currently empty
DV-B-120 is a competitive inhibitor of the dengue virus (DENV). It inhibits the NS2B-NS3 protease, effectively targeting DENV-1, DENV-2, DENV-3, and DENV-4 with IC50 values of 5.35, 7.39, 10.49, and 8.58 μM, respectively. DV-B-120 exerts its antiviral effects by inhibiting DENV replication.

| Description | DV-B-120 is a competitive inhibitor of the dengue virus (DENV). It inhibits the NS2B-NS3 protease, effectively targeting DENV-1, DENV-2, DENV-3, and DENV-4 with IC50 values of 5.35, 7.39, 10.49, and 8.58 μM, respectively. DV-B-120 exerts its antiviral effects by inhibiting DENV replication. |
| In vivo | DV-B-120 (1-10 mg/kg, twice daily, intracerebroventricular injection, 5 days) reduces mortality and related symptoms in ICR suckling mice infected with DENV-2 by activating interferon (IFN) and antiviral IFN-stimulated genes (ISG). |
| Formula | C23H18N2O5S2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.